• Please log in or register to access this feature.

Review

You have full text access to this OnlineOpen article

Extremity magnetic resonance imaging in rheumatoid arthritis: Report of the american college of rheumatology extremity magnetic resonance imaging task force

  1. Stanley Cohen MD*,
  2. American College Of Rheumatology Extremity Magnetic Resonance Imaging Task Force†,‡

Article first published online: 29 MAR 2006

DOI: 10.1002/art.21763

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 4, pages 1034–1047, April 2006

Additional Information

How to Cite

Cohen, S. and American College Of Rheumatology Extremity Magnetic Resonance Imaging Task Force (2006), Extremity magnetic resonance imaging in rheumatoid arthritis: Report of the american college of rheumatology extremity magnetic resonance imaging task force. Arthritis & Rheumatism, 54: 1034–1047. doi: 10.1002/art.21763

Author Information

  1. Department of Rheumatology, St. Paul University Hospital, 5939 Harry Hines Boulevard, Suite 400, Dallas, TX 75235

  1. †

    The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

  2. ‡

    Members of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force: Stanley Cohen, MD (Chair), Dallas, Texas; Atul Deodhar, MD, Portland, Oregon; Arthur Kavanaugh, MD, La Jolla, California; Hollis H. Potter, MD, New York, New York; Eric Ruderman, MD, Chicago, Illinois; Robert H. Shmerling, MD, Boston, Massachusetts; Barbara N. Weissman, MD, Boston, Massachusetts; Michael Weisman, MD, Los Angeles, California; Carl Winalski, MD, Boston, Massachusetts.

*American College of Rheumatology, 1800 Century Place, Suite 250, Atlanta, GA 30345

  1. †

    The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

  2. ‡

    Members of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force: Stanley Cohen, MD (Chair), Dallas, Texas; Atul Deodhar, MD, Portland, Oregon; Arthur Kavanaugh, MD, La Jolla, California; Hollis H. Potter, MD, New York, New York; Eric Ruderman, MD, Chicago, Illinois; Robert H. Shmerling, MD, Boston, Massachusetts; Barbara N. Weissman, MD, Boston, Massachusetts; Michael Weisman, MD, Los Angeles, California; Carl Winalski, MD, Boston, Massachusetts.

Publication History

  1. Issue published online: 29 MAR 2006
  2. Article first published online: 29 MAR 2006
  3. Manuscript Accepted: 12 JAN 2006
  4. Manuscript Received: 18 OCT 2005

Funded by

  • General Electric Health Care

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (104K)

REFERENCES

  • 1
    Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis [review]. J Rheumatol 1999; 26: 720–5.
  • 2
    Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985; 28: 1326–35.
    Direct Link:
  • 3
    Lipsky PE, van der heide DM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al, and the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594–602.
  • 4
    Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [published erratum appears in N Engl J Med 2001;344:240]. N Engl J Med 2000; 343: 1586–93.
  • 5
    Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004; 50: 1400–11.
    Direct Link:
  • 6
    Forslind K, Larsson EM, Johansson A, Svensson B. Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis. Br J Rheumatol 1997; 36: 683–8.
  • 7
    Foley-Nolan D, Stack JP, Ryan M, Redmond U, Barry C, Ennis J, et al. Magnetic resonance imaging in the assessment of rheumatoid arthritis: a comparison with plain film radiographs. Br J Rheumatol 1991; 30: 101–6.
  • 8
    Gilkeson G, Polisson R, Sinclair H, Vogler J, Rice J, Caldwell D, et al. Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. J Rheumatol 1988; 15: 1361–6.
  • 9
    McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, et al. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x-rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001; 60: 859–68.
  • 10
    Ostergaard M, Hansen M, Stoltenberg M, Jensen KE, Szkudlarek M, Pedersen-Zbinden B, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum 2003; 48: 2128–31.
    Direct Link:
  • 11
    Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003; 48: 64–71.
    Direct Link:
  • 12
    McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 1814–27.
    Direct Link:
  • 13
    Shellock FG, Kanal E. Magnetic resonance: bioeffects, safety and patient management. 2nd ed. New York: Lippincott-Raven; 1996.
  • 14
    Shellock FG. Reference manual for magnetic resonance safety, implants and devices. Los Angeles: Biomedical Research Publishing; 2005.
  • 15
    Shellock FG. Magnetic resonance procedures: health effects and safety. Boca Raton: CRC Press; 2001.
  • 16
    URL: http://www.radiology.upmc.edu/MRsafety/www.mrisafety.com.
  • 17
    URL: http://www.mrisafety.com.
  • 18
    Benton N, Stewart N, Crabbe J, Robinson E, Yeoman S, McQueen FM. MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis 2004; 63: 555–61.
  • 19
    Ostergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, et al. Magnetic resonance imaging–determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 918–29.
    Direct Link:
  • 20
    Tan AL, Grainger AJ, Tanner SF, Shelley DM, Pease C, Emery P, et al. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthitis Rheum 2005; 52: 2355–65.
    Direct Link:
  • 21
    Ostergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, et al. An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005; 64 Suppl 1: i3–7.
  • 22
    Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 1036–8.
  • 23
    Ejbjerg BJ, Vestergaard A, Jacobsen S, Thomsen HS, Ostergaard M. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score. Arthritis Rheum 2005; 52: 2300–6.
    Direct Link:
  • 24
    Bird P, Kirkham B, Portek I, Shnier R, Joshua F, Edmonds J, et al. Documenting damage progression in a two-year longitudinal study of rheumatoid arthritis patients with established disease (the DAMAGE study cohort): is there an advantage in the use of magnetic resonance imaging compared with plain radiography? Arthritis Rheum 2004; 50: 1383–9.
    Direct Link:
  • 25
    Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 1977; 18: 481–91.
  • 26
    Ejbjerg B, Narvestad E, Jacobsen S, Thomsen HS, Ostergaard M. Optimized low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: a comparison with conventional high-field MRI and radiography. Ann Rheum Dis 2005; 64: 1280–7.
  • 27
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 28
    Taouli B, Zaim S, Peterfy C, Lynch JA, Stork A, Guermazi A, et al. Rheumatoid arthritis of the hand and wrist: comparison of three imaging techniques. AJR Am J Roentgenol 2004; 182: 937–43.
  • 29
    Savnik A, Malmskov H, Thomsen HS, Bretlau T, Graff LB, Nielsen H, et al. MRI of the arthritic small joints: comparison of extremity MRI (0.2 T) vs high-field MRI (1.5 T). Eur Radiol 2001; 11: 1030–8.
  • 30
    Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum 2003; 48: 1207–13.
    Direct Link:
  • 31
    Crues JV, Shellock FG, Dardashti S, James TW, Troum OM. Identification of wrist and metacarpophalangeal joint erosions using a portable magnetic resonance imaging system compared to conventional radiographs. J Rheumatol 2004; 31: 676–85.
  • 32
    Lindegaard H, Vallo J, Horslev-Peterson K, Junker P, Ostergaard M. Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset. Ann Rheum Dis 2001; 60: 770–6.
  • 33
    Ejbjerg B, Narvestad E, Rostrup E, Szkudlarek M, Jacobsen S, Thomsen HS, et al. Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum 2004; 50: 1097–106.
    Direct Link:
  • 34
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 27–35.
    Direct Link:
  • 35
    Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727–35.
    Direct Link:
  • 36
    Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44–8.
    Direct Link:
  • 37
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
    Direct Link:
  • 38
    Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O’Connor PJ, Ridgway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002; 46: 366–72.
    Direct Link:
  • 39
    Vincken PW, ter Brakk BP, van Erkell AR, de Rooy TP, Mallens WM, Post W, et al. Effectiveness of MRI imaging in selection of patients for arthroscopy of the knee. Radiology 2002; 223: 739–46.
  • 40
    Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.
  • 41
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968; 37: 393–406.
  • 42
    Beattie KA, Boulos P, Pui M, O'Neill J, Webber CE, Adachi JD. Abnormalities identified in the knees of asymptomatic volunteers using peripheral magnetic resonance imaging. Osteoarthritis Cartilage 2005; 13: 181–6.
View Full Article (HTML) Get PDF (104K)